Key result
Patients with severe mental illness and comorbid coronary heart disease or heart failure were less likely to be prescribed beta blockers and ACEI/ARBs compared to those without severe mental illness.
Why the study?
Does severe mental illness reduce the likelihood of receiving guideline-directed medical therapy for cardiovascular disease?
Cross-Sectional (n=274,725)
Does severe mental illness reduce the likelihood of receiving guideline-directed medical therapy for cardiovascular disease?
Patients with severe mental illness and comorbid coronary heart disease or heart failure are significantly less likely to be prescribed guideline-directed beta blockers and ACEI/ARBs compared to those without severe mental illness.
Answers are grounded in this paper and cite their sources.
May signal care gaps in severe mental illness; observational data leaves open causality and needs prospective confirmation.
BACKGROUND: Suboptimal treatment of cardiovascular diseases (CVD) among patients with severe mental illness (SMI) may contribute to physical health disparities. AIM: To identify SMI characteristics associated with meeting CVD treatment and prevention guidelines. DESIGN AND SETTING: Population-based electronic health record database linkage between primary care and the sole provider of secondary mental health care services in south east London, UK. METHOD: Cardiovascular disease prevalence, risk factor recording, and Quality and Outcomes Framework (QOF) clinical target achievement were compared among 4056 primary care patients with SMI whose records were linked to secondary healthcare records and 270 669 patients without SMI who were not known to secondary care psychiatric services, using multivariate logistic regression modelling. Data available from secondary care records were then used to identify SMI characteristics associated with QOF clinical target achievement. RESULTS: Patients with SMI and with coronary heart disease and heart failure experienced reduced prescribing of beta blockers and angiotensin-converting enzyme inhibitor/angiotensin receptor blockers (ACEI/ARB). A diagnosis of schizophrenia, being identified with any indicator of risk or illness severity, and being prescribed with depot injectable antipsychotic medication was associated with the lowest likelihood of prescribing. CONCLUSION: Linking primary and secondary care data allows the identification of patients with SMI most at risk of undertreatment for physical health problems.
No takes yet. Share an insight, caveat, or question.
Woodhead et al. (2016) conducted a cross-sectional in Severe mental illness and cardiovascular disease (n=274,725). Severe mental illness vs. No severe mental illness was evaluated on Beta blocker prescribing among patients with coronary heart disease or heart failure (OR 0.48, 95% CI 0.33-0.69, p=<0.001). Patients with severe mental illness and comorbid coronary heart disease or heart failure were less likely to be prescribed beta blockers and ACEI/ARBs compared to those without severe mental illness.
Synapse has enriched 10 related papers. Consider them for comparative context: